Delafloxacin an Effective Option for Acute Bacterial Skin Infections

Delafloxacin is non-inferior to vancomycin plus aztreonam for treating acute bacterial skin and skin-structure infections (ABSSSI), according to a new phase 3 trial.
Reuters Health Information

http://ift.tt/2xOnHVX